Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,956,888
+$8,805,778 QoQ
Shares Held
515,343
+41.6% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#43
of 325 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. PCVX ranks #1 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
This page
|
515,343 | $29,956,888 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
845,118 | $29,908,726 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
419,773 | $25,337,498 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
647,836 | $24,105,977 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
95,335 | $23,335,147 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
1,051,465 | $22,985,024 | |
| 7 | MRNA |
Moderna, Inc.
|
274,820 | $19,245,644 | |
| 8 | MLYS |
Mineralys Therapeutics, Inc.
|
649,027 | $17,510,748 |
All Filings in PCVX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,956,888 | 515,343 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,151,110 | 363,984 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,111,635 | 67,439 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,200,806 | 172,149 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,862,813 | 149,579 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,121,319 | 56,179 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,981,428 | 73,069 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,489,896 | 39,292 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,624,123 | 34,752 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $909,206 | 13,310 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $903,692 | 14,390 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,263,794 | 24,790 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,098,680 | 22,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $818,450 | 21,837 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $1,092,120 | 45,505 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $638,090 | 29,324 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $228,797 | 9,474 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $303,703 | 12,766 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $286,325 | 11,286 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||